Corbyn Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Sell
33,944
-106
-0.3% -$9.29K 0.84% 41
2026
Q1
$3.08M Buy
34,050
+183
+0.5% +$16.8K 1.03% 32
2025
Q4
$3.05M Buy
33,867
+1,447
+4% +$137K 0.89% 38
2025
Q3
$3.19M Sell
32,420
-627
-2% -$62.1K 0.94% 35
2025
Q2
$3.01M Buy
33,047
+574
+2% +$55.5K 1.01% 35
2025
Q1
$3.68M Buy
32,473
+1,931
+6% +$207K 1.37% 26
2024
Q4
$3.23M Buy
30,542
+1,611
+6% +$173K 1.16% 34
2024
Q3
$3.12M Buy
28,931
+13,963
+93% +$1.52M 1.19% 30
2024
Q2
$1.62M Buy
+14,968
New +$1.76M 0.67% 40

Other funds holding ZBH

Corbyn Investment Management's ZBH Position: Q2 2026 in Review

Corbyn Investment Management reduced its Zimmer Biomet (ZBH) stake by 0.31% in Q2 2026, selling an estimated $9.29K and leaving 33,944 shares worth $2.92M. The position accounts for 0.84% of the portfolio, ranked #41.

Corbyn Investment Management first reported a position in ZBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.68M in Q1 2025. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Corbyn Investment Management held 33,944 shares of Zimmer Biomet worth $2.92M as of Q2 2026.
  • Corbyn Investment Management sold 106 Zimmer Biomet shares in Q2 2026, an estimated $9.29K.
  • Zimmer Biomet made up 0.84% of Corbyn Investment Management's portfolio in Q2 2026, its #41 holding.
  • Corbyn Investment Management first reported a position in Zimmer Biomet in Q2 2024 and has held it in 9 quarters since.
  • Corbyn Investment Management's Zimmer Biomet position peaked at $3.68M in Q1 2025.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Corbyn Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.